Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prophylactic Dexamethasone for Regorafenib-Related Fatigue in mCRC
NCT02288078Phase 2Unknown
- Sponsor
- Clinical Research Support Center Kyushu
- Start
- Oct 2014
- Primary completion
- Sep 2015
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in fatigue and malaise comparing Dexamethasone Group with Placebo Group (2 arms). Primary endpoint: Incidence of fatigue or malaise (CTCAE ver. 4, all grades) at 4 weeks. Status: unknown.
02
Drugs
dexamethasone
03
Conditions
fatiguemalaise
Beyond the preview
Go deeper on NCT02288078.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02288078.